Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ADAMS STREET PARTNERS LLC

Q4 2024 · 13F-HR

ADAMS STREET PARTNERS LLCholdings as filed

Filed 2025-02-14 · accession 0001104659-25-013428

$112.8M
Reported value
6
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
76674Q107RMNIRimini Street, Inc.$62.9M55.8%23,565,433CommonSOLE
221015100CRVSCorvus Pharmaceuticals, Inc.$17.5M15.5%3,275,616CommonSOLE
603170101MLYSMineralys Therapeutics, Inc.$13.9M12.3%1,129,807CommonSOLE
70439P108PAYPaymentus Holdings, Inc.$9.0M7.94%274,039CommonSOLE
697947109PVLAPalvella Therapeutics, Inc.$4.9M4.36%409,666CommonSOLE
91854V107Vacasa, Inc.$4.6M4.07%938,221CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.